Scott Young | VP Corporate Communications & IR |
Mike Clayman | CEO & Co-Founder |
Melissa Layman | Chief Commercial Officer |
David Arkowitz | CFO |
Daniel Busby | RBC Capital Markets |
Elliot Wilbur | Raymond James |
Gary Nachman | BMO Capital Markets |
Patrick Trucchio | Berenburg Capital Management |
Francois Brisebois | Craig-Hallum |
Serge Belanger | Needham & Company |
Carl Byrnes | Northland Capital |
Bruce Jackson | The Benchmark Company |
Good afternoon and welcome to the Flexion Therapeutics Fourth Quarter and Full Year 2019 Financial Results Conference Call. My name is Daniel, and I will be your coordinator for today. At this time, all participants are in listen-only mode.
We will be facilitating a question-and-answer session at the end of today's call. [Operator Instructions] I'll now turn the call over to the company.